XENE
Xenon Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
XENE Filings
Filing Date
Form Description
Form Type
2025-12-09
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-09 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-08
Form 144 - Report of proposed sale of securities
Ownership
2025-12-08 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-05
Form 144 - Report of proposed sale of securities
Ownership
2025-12-05 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-03
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-03 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-01
Form 144 - Report of proposed sale of securities
Ownership
2025-12-01 · Ownership
Form 144 - Report of proposed sale of securities
2025-12-01
Form S-8 - Securities to be offered to employees in employee benefit plans
Ownership
2025-12-01 · Ownership
Form S-8 - Securities to be offered to employees in employee benefit plans
2025-12-01
Form 8-K - Current report
Key Events
2025-12-01 · Key Events
Form 8-K - Current report
2025-11-14
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-14 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-03
Xenon Pharmaceuticals Inc. (XENE) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-03 · Earnings Call
Xenon Pharmaceuticals Inc. (XENE) Q3 2025 Earnings Call Transcript
2025-11-03
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-03 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
